1 results found.

Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontigu Clinical Trial using lenalidomide; rituximab; cyclophosphamide; doxorubicin hydrochloride; vincristine sulfate; prednisone; laboratory biomarker analysis; positron emission tomography

National Cancer Institute (NCI) - Recruiting 18 years or older.
- Randomized Phase II Open Label Study of Lenalidomide R-CHOP (R2CHOP) vs RCHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone) in Patients With Newly Diagnosed Diffuse Large B Cell Lymphoma.
lenalidomide; rituximab; cyclophosphamide; doxorubicin hydrochloride; vincristine sulfate; prednisone; laboratory biomarker analysis; positron emission tomography